Welcome to our dedicated page for ANAPTYSBIO SEC filings (Ticker: ANABV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ANAPTYSBIO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ANAPTYSBIO's regulatory disclosures and financial reporting.
ANAB notice of proposed sale: Morgan Stanley Smith Barney LLC intends to sell 35,000 shares of Common Stock on 06/11/2026 via a stock option exercise for $1,848,750.00 in cash. The filing also lists multiple recent open-market dispositions by Dennis Mulroy between 05/15/2026 and 06/10/2026, including several sales of 10,000–22,987 shares with disclosed gross proceeds per trade.
ANAB notice of proposed sale: Morgan Stanley Smith Barney LLC intends to sell 35,000 shares of Common Stock on 06/11/2026 via a stock option exercise for $1,848,750.00 in cash. The filing also lists multiple recent open-market dispositions by Dennis Mulroy between 05/15/2026 and 06/10/2026, including several sales of 10,000–22,987 shares with disclosed gross proceeds per trade.
ANAB affiliate filed a Form 144 disclosing multiple proposed and completed dispositions of Common Stock. The filing lists a 06/10/2026 stock option exercise of 20,000 shares (cash exercise) and a series of sales between 05/15/2026 and 06/09/2026 with individual share quantities and gross proceeds shown. The entries name Dennis Mulroy as the selling party and report per-trade proceeds in dollars alongside each share count.
ANAB affiliate filed a Form 144 disclosing multiple proposed and completed dispositions of Common Stock. The filing lists a 06/10/2026 stock option exercise of 20,000 shares (cash exercise) and a series of sales between 05/15/2026 and 06/09/2026 with individual share quantities and gross proceeds shown. The entries name Dennis Mulroy as the selling party and report per-trade proceeds in dollars alongside each share count.
ANAB: Notice of proposed sale of 20,000 shares of Common Stock via a stock option exercise on 06/09/2026, with cash proceeds indicated to the issuer. The filing lists multiple recent disposals by Dennis Mulroy in May–June 2026, including 21,987 shares on 06/08/2026 and 22,491 shares on 06/05/2026.
ANAB: Notice of proposed sale of 20,000 shares of Common Stock via a stock option exercise on 06/09/2026, with cash proceeds indicated to the issuer. The filing lists multiple recent disposals by Dennis Mulroy in May–June 2026, including 21,987 shares on 06/08/2026 and 22,491 shares on 06/05/2026.
ANAB affiliate reported proposed sales of Common Stock by Dennis Mulroy via a Form 144 notice. The filing lists multiple sales dates in May–June 2026 with individual transactions such as 22,491 shares for $1,153,671.22 on 06/05/2026 and several 20,000‑share entries in early June. The notice also shows equity awards/issuances including restricted stock grants and a 13,910 share stock option exercise on 06/08/2026.
ANAB affiliate reported proposed sales of Common Stock by Dennis Mulroy via a Form 144 notice. The filing lists multiple sales dates in May–June 2026 with individual transactions such as 22,491 shares for $1,153,671.22 on 06/05/2026 and several 20,000‑share entries in early June. The notice also shows equity awards/issuances including restricted stock grants and a 13,910 share stock option exercise on 06/08/2026.
ANAB (issuer) notice of proposed sale: the filing lists multiple planned dispositions of Common Stock by Dennis Mulroy via stock option exercises and cash settlements. The excerpt shows repeated sales dated from 05/15/2026 through 06/05/2026, with individual transactions such as 20,000 shares on 06/04/2026.
ANAB (issuer) notice of proposed sale: the filing lists multiple planned dispositions of Common Stock by Dennis Mulroy via stock option exercises and cash settlements. The excerpt shows repeated sales dated from 05/15/2026 through 06/05/2026, with individual transactions such as 20,000 shares on 06/04/2026.
ANAB reported a Form 144 registering 20,000 common shares for sale on 06/03/2026. The filing lists the sale method as Stock Option Exercise for 20,000 shares on 06/03/2026 for cash. The excerpt also records multiple sales by Dennis Mulroy during May–June 2026, including 15,000 shares on 05/29/2026 for $834,903.00 and other transactions totaling many tens of thousands of shares in the preceding weeks.
ANAB reported a Form 144 registering 20,000 common shares for sale on 06/03/2026. The filing lists the sale method as Stock Option Exercise for 20,000 shares on 06/03/2026 for cash. The excerpt also records multiple sales by Dennis Mulroy during May–June 2026, including 15,000 shares on 05/29/2026 for $834,903.00 and other transactions totaling many tens of thousands of shares in the preceding weeks.
ANAB affiliate filed a Form 144 proposing the sale of 20,000 shares of Common Stock via a Stock Option Exercise on 06/02/2026. The excerpt lists prior cash sales by Dennis Mulroy between 05/15/2026 and 06/01/2026, including individual sale amounts such as $928,071.04 for 15,467 shares on 05/21/2026.
ANAB affiliate filed a Form 144 proposing the sale of 20,000 shares of Common Stock via a Stock Option Exercise on 06/02/2026. The excerpt lists prior cash sales by Dennis Mulroy between 05/15/2026 and 06/01/2026, including individual sale amounts such as $928,071.04 for 15,467 shares on 05/21/2026.
ANAB affiliate reported a proposed resale of 7,691 shares. The filing states 06/01/2026 as the planned sale date and lists the transaction as a stock option exercise with proceeds in cash. The filing identifies Dennis Mulroy as the selling party and shows multiple recent dispositions in May 2026.
ANAB affiliate reported a proposed resale of 7,691 shares. The filing states 06/01/2026 as the planned sale date and lists the transaction as a stock option exercise with proceeds in cash. The filing identifies Dennis Mulroy as the selling party and shows multiple recent dispositions in May 2026.
AnaptysBio, Inc. is providing tax information to its stockholders about the dividend they received from the separation and spin-off of First Tracks Biotherapeutics, Inc. The company has filed IRS Form 8937 and is making the same information available in the Investors section of its website.
The Form 8937 explains how the spin-off dividend is treated for tax purposes and how stockholders should determine their adjusted tax basis. AnaptysBio emphasizes that this material is for informational purposes only and urges stockholders to consult their own tax advisors about their specific situations.
AnaptysBio, Inc. is providing tax information to its stockholders about the dividend they received from the separation and spin-off of First Tracks Biotherapeutics, Inc. The company has filed IRS Form 8937 and is making the same information available in the Investors section of its website.
The Form 8937 explains how the spin-off dividend is treated for tax purposes and how stockholders should determine their adjusted tax basis. AnaptysBio emphasizes that this material is for informational purposes only and urges stockholders to consult their own tax advisors about their specific situations.
ANAB filing under Rule 144 reports a proposed sale of 15,000 common shares via a stock option exercise on 05/29/2026. The filing lists multiple recent dispositions by Dennis Mulroy with trade dates and gross proceeds, including sales on 05/28/2026 (10,264 shares, $594,671.20) and earlier May sales.
ANAB filing under Rule 144 reports a proposed sale of 15,000 common shares via a stock option exercise on 05/29/2026. The filing lists multiple recent dispositions by Dennis Mulroy with trade dates and gross proceeds, including sales on 05/28/2026 (10,264 shares, $594,671.20) and earlier May sales.